🇺🇸 FDA
Patent

US 6313155

Composition and method for treating macular disorders

expired A61KA61K31/35A61K31/385

Quick answer

US patent 6313155 (Composition and method for treating macular disorders) held by The Board of Regents of the University of Texas System expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
106
CPC classes
A61K, A61K31/35, A61K31/385, A61K31/425, A61K31/535